Medicine and HealthCommunications Biology
Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients
D. Cantoní, M. Mayora-neto, et al.
In a surprising revelation, researchers, including Diego Cantoní and Martin Mayora-Neto, discovered that antibodies from SARS-CoV-2 infection or vaccination neutralize RaTG13 more efficiently than SARS-CoV-2. Their work suggests that current vaccination strategies could potentially mitigate future RaTG13 spillover, raising important implications for public health.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
A. Gharbaran, C. C. E. Jordans, et al.
Medicine and Health
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells
W. Hong, J. Yang, et al.
Medicine and Health
Prebiotic inulin ameliorates SARS-CoV-2 infection in hamsters by modulating the gut microbiome
I. Song, J. Yang, et al.
Medicine and Health
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters
J. R. Port, C. K. Yinda, et al.
